Search results
Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon
SciTechDaily· 19 hours agoVanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative ...
A Guide to Managing Covid This Summer
New York Times· 3 days agoHere’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoFood and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...
Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com
Investing.com· 6 days agoFood and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 3 days agoThe FDA delayed its decision on whether to approve the antiamyloid agent back in March, opting...
The Push to Get More People Into Long COVID Studies
Medscape· 3 days agoLast spring, he enrolled in a clinical trial of a new long COVID therapy at Stanford University, and he's about to start another at the University of...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 6 days agoInvivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 1 day agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...
EMA Panel Nods to Seven New Cancer Drugs
Medscape· 7 days agoThe drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.
MS Med Nearly Eliminates Disease Activity on MRI
Medscape· 2 days agoA second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data ...